Skip to main content
OpenTrials

Clinical trial condition

Primary Biliary Cholangitis

Explore clinical trials studying Primary Biliary Cholangitis. Study availability and eligibility vary by location and protocol.

52 public trials 15 recruiting studies
Refine in advanced search Browse all conditions

Primary Biliary Cholangitis trial results

Active, not recruiting

A Study of Elafibranor in Adult Japanese Participants With Primary Biliary Cholangitis (PBC)

NCT06730061

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • Nippon Medical School - Chiba Hokusoh Hospital Chiba, Japan
  • Fukushima Medical University Hospital Fukushima, Japan
  • Chugoku Rosai Hospital Hiroshima, Japan
  • Teine Keijinkai Hospital Hokkaido, Japan
View all 16 locations
View Trial Details
Active, not recruiting

A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis

NCT05050136

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholangitis, +16 more
Locations
  • Southern California Research Center Coronado, California, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • UC Davis Sacramento, California, United States
View all 130 locations
View Trial Details
Active, not recruiting

Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis

NCT06174402

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • The second hospital of Lanzhou University Lanzhou, Gansu, China
  • Sun Yat-sen Memorial Hospital Guangzhou, Guangdong, China
  • Jiangsu Province Hospital Nanjing, Jiangsu, China
  • Nanjing Drum Tower Hospital Nanjing, Jiangsu, China
View Trial Details
Active, not recruiting

Open-Label Extension Study of Saroglitazar Magnesium in Participants With Primary Biliary Cholangitis

NCT06427395

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • Zydus US013 Los Angeles, California, United States
  • Zydus US011 Pasadena, California, United States
  • Zydus US043 Sacramento, California, United States
  • Zydus US022 Aurora, Colorado, United States
View all 28 locations
View Trial Details
Active, not recruiting

Patients With Primary Biliary Cholangitis

NCT07573514

Conditions
Adenocarcinoma, Bile Duct Diseases, Biliary Tract Diseases, +20 more
Locations
  • Fondazione Policlinico Universitaro A. Gemelli IRCSS,UOC Medicina Interna e Gastroenterologia,Largo A. Gemelli, Roma, Italy
View Trial Details
Completed

Study to Evaluate the Efficacy and Safety of K-808 (Pemafibrate) in Participants With Primary Biliary Cholangitis (PBC) With Inadequate Response to Ursodeoxycholic Acid (UDCA) and/or Obeticholic Acid (OCA) Treatment.

NCT06247735

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • UA Thomas D. Boyer Liver Institute Tucson, Arizona, United States
  • Southern California Research Center - Coronado Coronado, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Velocity Clinical Research Santa Ana, California, United States
View all 38 locations
View Trial Details
Completed

Open-Label Study of HTD1801 in Adult Subjects With Primary Biliary Cholangitis

NCT04604652

Conditions
Bile Duct Diseases, Bile Duct Stricture, Biliary Tract Diseases, +12 more
Locations
  • University of Miami Schiff Center for Liver Disease Miami, Florida, United States
  • Piedmont Healthcare Atlanta, Georgia, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Henry Ford Health Services Detroit, Michigan, United States
View Trial Details
Completed

Study of OCA in Combination With BZF Evaluating Efficacy, Safety and Tolerability in Participants With PBC

NCT05239468

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Southern California Gastrointestinal (GI) and Liver Centers (SCLC) - Coronado Coronado, California, United States
  • Facey Medical Group Mission Hills, California, United States
  • Schiff Center for Liver Diseases / University of Miami Miami, Florida, United States
View all 26 locations
View Trial Details
Completed

A Study of Elafibranor in Adults With Primary Biliary Cholangitis and Inadequate Response or Intolerance to Ursodeoxycholic Acid.

NCT06383403

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • Southern California Research Center Coronado, California, United States
  • Topgraphy Health, Inc. Los Angeles, California, United States
  • University of California, Davis Sacramento, California, United States
  • Stanford University Medical Center Stanford, California, United States
View all 60 locations
View Trial Details

Related conditions